Torno Capital, LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Torno Capital, LLC
- $387 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding RVPH
# of Institutions
59Shares Held
7.74MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$739,6770.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$629,0690.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$266,7960.16% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3641KShares$262,8810.18% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$209,2340.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $8.38M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...